Current through Register Vol. 51, No. 19, September 20, 2024
A. The prescriber-pharmacist agreement shall
contain the following:
(1) The names and
signatures of the physicians, podiatrists, or certified advanced practice
nurses with prescriptive authority and pharmacists authorized to act under a
therapy management contract;
(2)
The locations where the pharmacists may provide therapy management
services;
(3) The titles of the
protocols to which the prescriber-pharmacist agreement pertains;
(4) The methods and time frames by which
documentation and routine communication will occur between the physicians,
podiatrists, or certified advanced practice nurses with prescriptive authority
and the pharmacists, including the time frames in which the pharmacist will
fully update the patient's record in writing;
(5) The name, address, and telephone number
of the party to the prescriber-pharmacist agreement who is to receive
correspondence from the Boards related to the prescriber-pharmacist
agreement;
(6) A statement that the
physicians, podiatrists, or certified advanced practice nurses with
prescriptive authority and pharmacists shall comply with all State and federal
laws relating to patient confidentiality; and
(7) A list of devices available to the
pharmacists performing under the prescriber-pharmacist agreement, which are
relevant to the disease-states or conditions to be managed.
B. Technical modifications to the
prescriber-pharmacist agreement shall be registered with the Board of Pharmacy
within 30 days of the technical modification.
C. The party designated as the contact person
to receive correspondence from the Boards shall ensure that the parties to the
prescriber-pharmacist agreement are notified in a timely manner of the
information received from the Boards.
D. If the contact information for the party
to the agreement designated to receive correspondence from the Boards changes,
the designee shall notify the Boards of the change within 30 days of the
change.
